TXA for GI Bleeds? The HALT-IT Trial

July 15, 2020 00:26:28
TXA for GI Bleeds?  The HALT-IT Trial
Critical Care Perspectives in Emergency Medicine
TXA for GI Bleeds? The HALT-IT Trial

Jul 15 2020 | 00:26:28

/

Show Notes

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. 

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

March 05, 2020 00:26:10
Episode Cover

COVID-19 Update - March 2020

In December 2019 a novel coronavirus (now named COVID-19) was identified as responsible for a cluster of pneumonia cases in Wuhan, China. As of...

Listen

Episode

April 15, 2025 00:25:31
Episode Cover

When Should We Start Vasopressin in Septic Shock?

Sepsis results in more than 250,000 deaths each year in the United States. Resuscitation of the septic patient centers on timely recognition, early antibiotic...

Listen

Episode 0

October 24, 2023 00:33:10
Episode Cover

SCCM Guidelines for RSI in the Critically Ill

RSI is one of the most common procedures in critically ill patients.  Despite its frequency, there remains significant practice variation on numerous aspects of...

Listen